Analysis of Cause-Specific Mortality in Patients with Retinoblastoma

Figure 1

Eligibility evaluation flow diagram for 12 RB cause-specific mortality patients. A total of 3780 RB patients were initially screened. After excluding 3516 survivors, 264 RB patients who died were included. After excluding 252 patients for intracranial tumor, abandonment of treatment, or other reasons, 12 RB cause-specific mortality patients were finally included.